Michael Brenner
Company: Harvard Medical School
Job title: Professor - Medicine
Seminars:
Discovering Granzyme K as a Potential 4th Complement Pathway 4:00 pm
Granzyme K as an activator of the complement cascade through the cleavage of C2 and C4 proteins Detailing the specific biomarker strategy employed in Empasiprubart trials for MMN, highlighting how these markers are used to assess disease activity, predict treatment response, and monitor therapeutic impact Exploring the implications of the biomarker strategy for future clinical…Read more
day: Conference Day One